
| Violation Category | Number of Violation Occurrences | ||
|---|---|---|---|
| 05‑06 | 06‑07 | 07‑08 | |
| Hazardous ingredients | |||
| Chemical identity not disclosed | 72 | 51 | 72 |
| Chemical identity incorrectly disclosed | 53 | 51 | 9 |
| CAS registry no. not disclosed | 40 | 68 | 157 |
| Concentration not disclosed | 64 | 35 | 153 |
| Concentration incorrectly disclosed | 55 | 46 | 12 |
| Concentration ratios missing or incorrect | 49 | 6 | 43 |
| Generic chemical identity | |||
| (For the claimed trade secret ingredient) | 43 | 53 | 106 |
| Preparation information | |||
| (Preparer’s name, telephone number, date of preparation—at least one missing) | 232 | 237 | 251 |
| Product information | |||
| Manufacturer—supplier identity, etc. | 34 | 4 | 9 |
| Product use | 21 | 11 | 8 |
| Physical data | |||
| Odour & appearance | 72 | 64 | 75 |
| Other | 23 | 28 | 10 |
| Fire or explosion hazard | |||
| Flash points | 8 | 18 | 10 |
| Hazardous combustion products not disclosed | 50 | 34 | 99 |
| Reactivity data | |||
| Stability | 1 | 2 | 11 |
| Incompatibility | 90 | 12 | 4 |
| Hazardous decomposition products not disclosed | 16 | 19 | 53 |
| Toxicological properties | |||
| LD50 (oral) not disclosed | 121 | 54 | 113 |
| LD50 (dermal) not disclosed | 55 | 24 | 59 |
| LC50 (inhalation) not disclosed | 74 | 35 | 47 |
| Route of entry | 24 | 14 | 17 |
| Effects of acute exposure | 130 | 47 | 190 |
| Effects of chronic exposure | 119 | 31 | 74 |
| Exposure limits | 76 | 41 | 109 |
| Irritancy | 14 | 5 | 5 |
| Corrosivity | 18 | 17 | 10 |
| Sensitization (dermal) | 11 | 7 | 3 |
| Sensitization (respiratory) | 13 | 15 | 3 |
| Carcinogenicity | 18 | 3 | 7 |
| Reproductive toxicity | 9 | 13 | 0 |
| Development toxicity | 83 | 29 | 51 |
| Mutagenicity | 64 | 31 | 33 |
| Synergism | 21 | 6 | 12 |
| Preventive measures | |||
| Leak/spill procedures | 2 | 0 | 0 |
| Waste disposal | 1 | 1 | 0 |
| Handling procedures | 6 | 4 | 10 |
| Storage | 5 | 1 | 2 |
| First aid measures | |||
| Aspiration risk | 52 | 37 | 11 |
| Remove advice to administer water in cases of ingestion | 83 | 48 | 44 |
| CPR | 65 | 32 | 20 |
| Eye contact measures | 84 | 58 | 33 |
| Skin contact measures | 56 | 64 | 64 |
| Other | 30 | 10 | 12 |
| Hazard classification | |||
| Class B | 11 | 0 | 3 |
| Class D1 | 30 | 15 | 26 |
| Class D2 | 25 | 24 | 26 |
| Class E | 10 | 14 | 13 |
| Format—Wording | 57 | 82 | 104 |
| Headings | 52 | 41 | 54 |
| Registry Number—Date of Filing | 263 | 59 | 58 |
| Total | 2,605 | 1,601 | 2,288 |
| Number of claims—controlled products | 298 | 192 | 284 |
| Average number of violation occurrences per claim | 8.7 | 8.34 | 8.06 |